Ask AI

Multidisciplinary Strategies for Integrating Immunotherapy Into Patient-Centered Management of Resectable Early-Stage NSCLC

Optimize clinical outcomes and quality of life for each patient with early-stage NSCLC by increasing your knowledge of evidence-based immunotherapy approaches and expert recommendations through downloadable slides, a downloadable patient education resource, certified Medical Minute modules, certified “Oncologist-on-Call” mentorship podcasts, and ClinicalThought commentaries.

Share

Program Content

Activities

IO ES NSCLC
Immunotherapy in Resectable Early-Stage NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 20, 2026

Activities

Early Stage NSCLC IO Resource
Talking About Immunotherapy: A Guide for Patients With Early-Stage NSCLC
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2026

Activities

Biomarker Testing and Immunotherapy in Early NSCLC
Biomarker-Guided Immunotherapy Decisions in Early-Stage NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 08, 2026

Expires: April 07, 2027

Immunotherapy Delivery in Early NSCLC
Optimizing Immunotherapy Delivery and Safety in NSCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 12, 2026

Expires: April 11, 2027

Activities

ES NSCLC Forum
Call To Action: Individualizing Treatment Plans in Resectable Early-Stage NSCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 04, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with Smart Patients.

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC

Partners

Smart Patients

ProCE Banner